[Anti-inflammatory activities of compounds related to anthranilic acid. II. On acridine mono- and dicarboxylic, and oxo-acridan monocarboxylic acid derivatives].
D000166:Acridines / Q000494:pharmacology*; D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002264:Carboxylic Acids / Q000494:pharmacology; D002351:Carrageenan; D002417:Cattle; D002738:Chloroquine / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D004487:Edema / Q000139:chemically induced; D005439:Flufenamic Acid / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects; D008297:Male; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011489:Protein Denaturation / Q000187:drug effects; D051381:Rats; D012710:Serum Albumin, Bovine; D013870:Thiomalates / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000166:Acridines; D000893:Anti-Inflammatory Agents; D002264:Carboxylic Acids; D013870:Thiomalates; D062367:ortho-Aminobenzoates; D000632:Aminopyrine; D012710:Serum Albumin, Bovine; D005439:Flufenamic Acid; D002738:Chloroquine; D002351:Carrageenan; D011239:Prednisolone; D010653:Phenylbutazone